What Happened?
Montana, AK-based Microbion Appointed Karim Lalji as Chairman and Chief Executive Officer
Date of management change: July 15, 2019
Montana, AK-based Microbion Appointed Karim Lalji as Chairman and Chief Executive Officer
Microbion is a clinical stage biopharmaceutical company. Microbion is developing MBN-101 as the first product in the bismuth-thiol class for the treatment of resistant and difficult to treat infections. MBN-101 has broad spectrum, anti-bacterial efficacy against a broad range of pathogens, including multiple priority pathogens or “superbugs”. In addition to anti-bacterial efficacy, MBN-101 also has highly advantageous and product-differentiating capability to prevent and eradicate microbial biofilms. The dual action from this first in class product provides a novel clinical approach to treating infections. Their effectiveness against MRSA, MDR TB, CRE, VRE, and other antibiotic resistant pathogens highlights their potential to provide solutions to the dramatic and alarming increase in global antibiotic resistance.
Karim Lalji is Chairman and Chief Executive Officer at Microbion. Previously, Karim held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Gervasi Linda, R�rmark Rebecca, Nguyen Josh, Corker Lynn, Villar Holly, Ellingsen Heather, Kelley Chris, Battle Bettsye, Melik Ludwig, McDaniel Michael, Greeley Kevin
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.